Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Parkinson's Disease

Free Subscription 09.03.2026 1 Exp Neurol 2 J Neural Transm (Vienna) 1 J Neurol Neurosurg Psychiatry 1 J Neurosci 5 Mov Disord 1 Nat Rev Neurol 1 Nature 1 Neurochem Res 1 Neuropsychology 1 PLoS One 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Exp Neurol

1. KABAOGLU B, Garulli EL, De Sa R, Vogt A, et al
   Shift in motor-state equilibrium explains gait therapy effects of apomorphine in experimental Parkinsonism.
   Exp Neurol. 2026 Feb 27:115704. doi: 10.1016/j.expneurol.2026.115704.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

2. MANTOVANI E, Bertoncello E, Filippetti M, Picelli A, et al
   Non-invasive brain stimulation for treating cognitive and neuropsychiatric non-motor symptoms in Parkinson's disease and atypical parkinsonism: a systematic review and meta-analysis of randomized controlled trials.
   J Neural Transm (Vienna). 2026 Mar 5. doi: 10.1007/s00702-026-03127.
   PubMed        
   
   
3. PARK M, Kwon J, Sohn YH, Lee PH, et al
   Language impairment as a risk factor for dementia conversion in parkinson's disease with mild cognitive impairment: a quantitative EEG study.
   J Neural Transm (Vienna). 2026 Feb 28. doi: 10.1007/s00702-026-03103.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

4. JOST ST, Atwani C, Loehrer PA, Ashkan K, et al
   Patients with symmetric Parkinson's disease do poorly with subthalamic stimulation.
   J Neurol Neurosurg Psychiatry. 2026 Mar 4:jnnp-2025-336382.
   PubMed         Abstract available
   
   

   
   J Neurosci

5. GALVAN A, Hu X, Martel AC, Heffernan KS, et al
   Temporal Variability in the Spiking Activity of Neurons in the External Globus Pallidus in Healthy and Parkinsonian Monkeys.
   J Neurosci. 2026 Mar 2:e1283252026. doi: 10.1523/JNEUROSCI.1283-25.2026.
   PubMed         Abstract available
   
   

   
   Mov Disord

6. KOUCHACHE T, Zolfaghari S, Bouhadoun S, Delva A, et al
   Reply to Comment on "Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease".
   Mov Disord. 2026 Mar 6. doi: 10.1002/mds.70255.
   PubMed        
   
   
7. SCHALKAMP AK, Peall KJ, Harrison NA, Sandor C, et al
   Comment on "Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease".
   Mov Disord. 2026 Mar 5. doi: 10.1002/mds.70253.
   PubMed        
   
   
8. GABRIEL ED, Eisinger RS, Lee JM, Hamimi S, et al
   When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions.
   Mov Disord. 2026 Mar 4. doi: 10.1002/mds.70258.
   PubMed         Abstract available
   
   
9. COLE-HUNTER T, Antic S, Lim YH, Zhang J, et al
   Long-Term Exposure to Air Pollution and Incidence of Parkinson's Disease: A Danish Nationwide Administrative Cohort Study.
   Mov Disord. 2026 Mar 2. doi: 10.1002/mds.70234.
   PubMed         Abstract available
   
   
10. PAINOUS C, Fernandez M, Camara A, Alba-Arbalat S, et al
    Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases.
    Mov Disord. 2026;41:500-508.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

11. DOMMERSHUIJSEN LJ, Darweesh SKL, Bloem BR
    Epidemiological principles behind worldwide growth of Parkinson disease - a bathtub analogy.
    Nat Rev Neurol. 2026 Mar 4. doi: 10.1038/s41582-026-01193.
    PubMed        
    
    

    
    Nature

12. DE SCHEPPER S, Konstantellos V, Conway JA, Sokolova D, et al
    Intestinal macrophages modulate synucleinopathy along the gut-brain axis.
    Nature. 2026;651:174-184.
    PubMed         Abstract available
    
    

    
    Neurochem Res

13. PEREZ-BARRON G, Sanchez-Gonzalez K, Cruz SL, Lopez-Rubalcava C, et al
    Antidepressant-like effect of hydroxytyrosol in a 1-methyl-4-phenylpyridinium model of Parkinson's disease in rats.
    Neurochem Res. 2026;51:99.
    PubMed        
    
    

    
    Neuropsychology

14. HUANG H, Zhu R, Zheng Y, Lin N, et al
    Effect evaluation of the positive emotion, engagement, relationships, meaning, and accomplishment (PERMA) positive psychological intervention model in patients with Parkinson's disease.
    Neuropsychology. 2026;40:216-227.
    PubMed         Abstract available
    
    

    
    PLoS One

15. BAGGEN RJ, Van Bladel A, Prins MR, Stappers J, et al
    Visual perturbation training to reduce visual dependency in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2026;21:e0343223.
    PubMed         Abstract available
    
    

    
    Rev Neurol

16. LARA-GIRON JC, Sanchez-Diaz D, Sanabria-Sanchinel AA, Escobar-Pineda ES, et al
    Unilateral Microelectrode Recording-Guided Pallidotomy in Advanced Parkinson's Disease: Clinical and Neuropsychological Outcomes in a Guatemalan Cohort.
    Rev Neurol. 2026;81:44171.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum